National patterns in antidepressant treatment by psychiatrists and general medical providers: Results from the National Comorbidity Survey Replication

Journal of Clinical Psychiatry

Volumn 69, Issue 7, 2008, Pages 1064-1074

  Mojtabai, Ramin ^a   Olfson, Mark ^b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; IMIPRAMINE; MIRTAZAPINE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SERTRALINE; TRAZODONE; VENLAFAXINE;

ADULT; AGE DISTRIBUTION; AGED; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE REGISTRY; DISTRESS SYNDROME; FEMALE; GENERAL PRACTITIONER; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIST; TREATMENT DURATION;

EID: 47749121008     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0704     Document Type: Article

References (44)

1. Olfson M, Marcus SC, Druss B, et al. National trends in the outpatient treatment of depression. JAMA 2002;287:203-209
2. Kessler RC, Demler O, Frank RG, et al. Prevalence and treatment of mental disorders. 1990 to 2003. N Engl J Med 2005;352:2515-2523
3. Kravilz RL, Epstein RM, Feldman MD, et al. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA 2005;293:1995-2002
4. Greenfield SF, Reizes JM, Muenz LR, et al. Treatment for depression following the 1996 National Depression Screening Day. Am J Psychiatry 2000;157:1867-1869
5. Frank RG, Glied S. Better but Not Well: Mental Health Policy in the United States Since 1950. Baltimore, Md: Johns Hopkins University Press; 2006
6. Kramer PD. Listening to Prozac. New York, NY: Penguin Books; 1997
7. Beardsley RS, Gardocki GJ, Larson DB, et al. Prescribing of psychotropic medication by primary care physicians and psychiatrists. Arch Gen Psychiatry 1988;45:1117-1119
8. Pincus HA, Tanielian TL, Marcus SC, et al. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA 1998;279:526-531
9. Croghan TW, Melfi CA, Dobrez DG, et al. Effect of mental health specialty care on antidepressant length of therapy. Med Care 1999;37: AS20-AS23
10. Kerr MP. Antidepressant prescribing: a comparison between general practitioners and psychiatrists. Br J Gen Pract 1994;44:275-276
11. McManus P, Mant A, Mitchell P, et al. Use of antidepressants by general practitioners and psychiatrists in Australia. Aust N Z J Psychiatry 2003; 37:184-189
12. Mojtabai R. Datapoints: prescription patterns for mood and anxiety-disorders in a community sample. Psychiatr Serv 1999;50:1557
13. Olfson M, Klerman GL. The treatment of depression: prescribing practices of primary care physicians and psychiatrists. J Fam Pract 1992:35: 627-635
14. Bambauer KZ, Soumerai SB, Adams AS, et al. Provider and patient characteristics associated with antidepressant nonadhcrence: the impact of provider specialty. J Clin Psychiatry 2007;68:867-873
15. Cooper-Patrick L, Crum RM, Ford DE. Characteristics of patients with major depression who received care in general medical and specialty mental health settings. Med Care 1994;32:15-24
16. Van Voorhees BW, Cooper LA, Rost KM, et al. Primary care patients with depression are less accepting of treatment than those seen by mental health specialists. J Gen Intern Med 2003;18:991-1000
17. Wittchen HU. Reliability and validity studies of the WHO Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 1994;28:57-84
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Washington, DC: American Psychiatric Association; 1994
19. Kessler RC, Barker PR, Colpe LJ, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry 2003;60:184-189
20. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder (revision). Am J Psychiatry 2000; 157(suppl 4): 1-45
21. Olfson M, Marcus SC, Tedeschi M, et al. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry 2006;163:101-108
22. Hosmer DW. Lemeshow S. Applied Logistic Regression. 2nd ed. New York, NY: Wiley; 2000
23. StataCorp. Stata Statistical Software, Release 9.2. College Station, Tex: Stata Corporation; 2006
24. Posternak MA, Zimmerman M. How accurate are patients in reporting their antidepressant treatment history? J Affect Disord 2003;75:115-124
25. Guaiana G, Andretta M, Corbari L, et al. Antidepressant drug consumption and public health indicators in Italy, 1955 to 2000. J Clin Psychiatry 2005;66:750-755
26. Helgason T, Tomasson H, Zoega T. Antidepressants and public health in Iceland: time series analysis of national data. Br J Psychiatry 2004;184: 157-162
27. Patten SB, Beck C. Major depression and mental health care utilization in Canada: 1994 to 2000. Can J Psychiatry 2004;49:303-309
28. Mojtabai R. Trends in contacts with mental health professionals and cost barriers to mental health care among adults with significant psychological distress in the United States: 1997-2002. Am J Public Health 2005; 95:2009-2014
29. Croghan TW. The controversy of increased spending for antidepressants. Health Aff (Millwood) 2001;20:129-135
30. Druss BG. Rising mental health costs: what are we getting for our money? Health Aff (Millwood) 2006;25:614-622
31. Simon GE, Von Korff M, Rutter CM, et al. Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians. Arch Gen Psychiatry 2001;58:395-401
32. Suh T, Gallo JJ. Symptom profiles of depression among general medical sendee users compared with specialty mental health service users. Psychol Med 1997;27:1051-1063
33. Williamson PS, Yates WR. The initial presentation of depression in family practice and psychiatric outpatients. Gen Hosp Psychiatry 1989; 11:188-193
34. Lewis E, Marcus SC, Olfson M, et al. Patients' early discontinuation of antidepressant prescriptions. Psychiatr Serv 2004;55:494
35. Robinson RL, Long SR, Chang S, et al. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims. J Manag Care Pharm 2006;12:43-54
36. Weilburg JB, O'Leary KM, Meigs JB, et al. Evaluation of the adequacy of outpatient antidepressant treatment. Psychiatr Serv 2003;54: 1233-1239
37. Bull SA, Hu XH, Hunkeler EM, et al. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA 2002;288:1403-1409
38. Sirey JA, Brace ML, Alexopoulos GS, et al. Stigma as a barrier to recovery: perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv 2001; 52:1615-1620
39. Patience D. Dosage of antidepressant medication dispensed in Scotland. Health Bull (Edinb) 1997;55:322-325
40. Onghena P, Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 1992;49:205-219
41. Bon OL. Low-dose trazodone effective in insomnia. Pharmacopsychiatry 2005;38:226
42. Wang PS, Dernier O, Olfson M, et al. Changing profiles of service sectors used for mental health care in the United States. Am J Psychiatry 2006;163:1187-1198
43. Baldwin LM, Patanian MM, Larson EH, et al. Modeling the mental health workforce in Washington State: using state licensing data to examine provider supply in rural and urban areas. J Rural Health 2006;22: 50-58
44. Lambert D, Agger M, Hartley D. Service use of rural and urban Medicaid beneficiaries suffering from depression: the role of supply. J Rural Health 1999;15:344-355